DADC
HAE icon

D.A. Davidson & Co’s Haemonetics HAE Stock Holding History

D.A. Davidson & Co’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,039
Closed -$162K – 2393
2016
Q4 		$162K Sell
4,039
-40
-1% -$1.51K ﹤0.01% 1087
2016
Q3 		$147K Buy
4,079
+25
+0.6% +$858 ﹤0.01% 1075
2016
Q2 		$117K Sell
4,054
-85,292
-95% -$2.58M ﹤0.01% 1054
2016
Q1 		$3.12M Buy
89,346
+6,654
+8% +$215K 0.1% 203
2015
Q4 		$2.67M Sell
82,692
-5,055
-6% -$164K 0.09% 214
2015
Q3 		$2.83M Buy
87,747
+84,288
+2,437% +$3.17M 0.1% 198
2015
Q2 		$143K Buy
3,459
+40
+1% +$1.69K ﹤0.01% 996
2015
Q1 		$153K Buy
3,419
+34
+1% +$1.42K 0.01% 971
2014
Q4 		$126K Hold
3,385
– – ﹤0.01% 1031
2014
Q3 		$118K Hold
3,385
– – ﹤0.01% 1050
2014
Q2 		$119K Hold
3,385
– – ﹤0.01% 1068
2014
Q1 		$110K Sell
3,385
-1,743
-34% -$66.6K ﹤0.01% 1090
2013
Q4 		$215K Sell
5,128
-11
-0.2% -$453 0.01% 814
2013
Q3 		$204K Buy
5,139
+638
+14% +$26.8K 0.01% 693
2013
Q2 		$185K Buy
+4,501
New +$182K 0.01% 692

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

D.A. Davidson & Co's HAE Position: Q1 2017 in Review

D.A. Davidson & Co sold out of Haemonetics (HAE) in Q1 2017, closing a stake of 4,039 shares — an estimated $162K sold.

D.A. Davidson & Co first reported a position in HAE in Q2 2013 and held it in 15 quarters. The position peaked at $3.12M in Q1 2016. 181 funds tracked by Wall St. Rank hold HAE as of Q1 2017.

  • D.A. Davidson & Co reported no remaining Haemonetics position as of Q1 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 4,039 Haemonetics shares in Q1 2017, an estimated $162K.
  • D.A. Davidson & Co first reported a position in Haemonetics in Q2 2013 and held it in 15 quarters.
  • D.A. Davidson & Co's Haemonetics position peaked at $3.12M in Q1 2016.
  • 181 funds tracked by Wall St. Rank held Haemonetics as of Q1 2017.

Based on D.A. Davidson & Co's 13F filing for Q1 2017, filed 12 May 2017.